Skip to main content
Top
Published in: Familial Cancer 1/2010

01-03-2010

Predictive genetic testing in a young child: a case report

Authors: Gillian Crawford, Anneke Lucassen

Published in: Familial Cancer | Issue 1/2010

Login to get access

Excerpt

The many different professional guidelines [1] that give advice about genetic testing in children have been extensively reviewed in other papers in this issue of the journal. Here we present a case report illustrating how the issue of genetic testing in children continues to present challenges to clinical teams in practice. The identifying details of the case have been altered to preserve the anonymity of the family involved. …
Literature
1.
go back to reference Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K (2006) Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 70:374–381CrossRefPubMed Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K (2006) Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 70:374–381CrossRefPubMed
2.
go back to reference Vasen HFA (2000) Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 18(21s):81–92 Vasen HFA (2000) Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 18(21s):81–92
3.
go back to reference Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, Slominski-Castor S, Cayouette MC, Priluck I, Luce MC (1995) Attenuated Familial Adenomatous Polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 76(12):2427–2433CrossRefPubMed Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, Slominski-Castor S, Cayouette MC, Priluck I, Luce MC (1995) Attenuated Familial Adenomatous Polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 76(12):2427–2433CrossRefPubMed
4.
go back to reference Clarke AJ, Gaff C (2008) Challenges in the genetic testing of children for familial cancers. Arch Dis Child 93(11):911–914CrossRefPubMed Clarke AJ, Gaff C (2008) Challenges in the genetic testing of children for familial cancers. Arch Dis Child 93(11):911–914CrossRefPubMed
5.
go back to reference Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS (2004) Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 8:33 Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS (2004) Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 8:33
6.
go back to reference Locock L, Kai J (2008) Parents’ experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 58:161–168CrossRefPubMed Locock L, Kai J (2008) Parents’ experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 58:161–168CrossRefPubMed
7.
go back to reference McConkie-Rosell A, Spiridigliozzi GA (2004) ‘Family matters’: a conceptual framework for genetic testing in children. J Genet Couns 13(1):9–29CrossRefPubMed McConkie-Rosell A, Spiridigliozzi GA (2004) ‘Family matters’: a conceptual framework for genetic testing in children. J Genet Couns 13(1):9–29CrossRefPubMed
8.
go back to reference Dalby S (1995) GIG response to the UK clinical genetics society report ‘the genetic testing of children’ June. British Medl J 32(6):490–491 Dalby S (1995) GIG response to the UK clinical genetics society report ‘the genetic testing of children’ June. British Medl J 32(6):490–491
Metadata
Title
Predictive genetic testing in a young child: a case report
Authors
Gillian Crawford
Anneke Lucassen
Publication date
01-03-2010
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-009-9277-1

Other articles of this Issue 1/2010

Familial Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine